TerminatedNCT03169868
Enhanced Medication Reconciliation For Serious Mental Illness
Study assessmentsAges 21+United StatesMental health
Understand this study
Who could participate?
Listed age limits: from 21 years.
- Listed locations
- PittsburghSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 27, 2018
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 26
- Sponsor
- Precera Bioscience, Inc.
- Sponsor type
- Biotech company
- Study type
- Diagnostic Test
- Intervention type
- DIAGNOSTIC_TEST
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- Over 21 Years
- Official registry ID
- NCT03169868
- Official title
Show the full official title
A Pilot Prospective, Randomized Controlled Trial Assessing Enhanced Medication Reconciliation With a Clinical Decision Support Tool in Patients With Serious Mental Illness.
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Questions about this study
Who is behind this study?
The study sponsor is Precera Bioscience, Inc.
Who can participate?
Listed age limits: from 21 years.
Is this study still recruiting?
The registry lists this study as terminated.
